Glesatinib hydrochloride ( MGCD-265 hydrochloride )

Catalog No. M10436 CAS No. 1123838-51-6

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Group Booking Get Quotation Bulk Inquiry Add to Cart

Product Name

Glesatinib hydrochloride
Note

Research use only, not for human use.
Brief Description

Glesatinib (MGCD-265) is a tyrosine kinase inhibitor that potently and selectively inhibits Met and Axl kinase.
Description

Glesatinib (MGCD-265) is a tyrosine kinase inhibitor that potently and selectively inhibits Met and Axl kinase.Lung Cancer Phase 2 Clinical
Synonyms

MGCD-265 hydrochloride
Pathway

Tyrosine Kinase
Target

TAM Receptor
Recptor

TAM Receptor
Research Area

Cancer
Indication

Lung Cancer

CAS Number

1123838-51-6
Formula Weight

655.16
Molecular Formula

C31H27ClF2N5O3S2X
Purity

>98% (HPLC)
Solubility

DMSO: ≥ 28 mg/mL
SMILES

COCCNCC1=CN=C(C=C1)C2=CC3=NC=CC(=C3S2)OC4=C(C=C(C=C4)NC(=S)NC(=O)CC5=CC=C(C=C5)F)F.Cl
Chemical Name

Benzeneacetamide, 4-fluoro-N-[[[3-fluoro-4-[[2-[5-[[(2-methoxyethyl)amino]methyl]-2-pyridinyl]thieno[3,2-b]pyridin-7-yl]oxy]phenyl]amino]thioxomethyl]-, hydrochloride (1:x)